Ebrantil and Voltaren drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ebrantil (urapidil) and Voltaren (diclofenac sodium). Common drug interactions include dehydration among females and haemoglobin decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Ebrantil and Voltaren. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Ebrantil?
Ebrantil has active ingredients of urapidil. eHealthMe is studying from 1,656 Ebrantil users. Check the latest studies of Ebrantil.
What is Voltaren?
Voltaren has active ingredients of diclofenac sodium. It is often used in arthritis. eHealthMe is studying from 82,346 Voltaren users. Check the latest studies of Voltaren.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
29 people who take Ebrantil and Voltaren together, and have interactions are studied.

What are the common drug interactions of Ebrantil and Voltaren, by gender? *:
female:
- Dehydration (dryness resulting from the removal of water)
- Urinary tract infection
- Anaemia folate deficiency (lack of blood due to deficiency of folate)
- Drug eruption (adverse drug reaction of the skin)
- Embolism venous (embolus may pass into the arterial system)
- Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
- Osteoporosis (bones weak and more likely to break)
- Purpura (purplish discoloration of the skin)
- Pyelonephritis acute (sudden inflammation of kidney caused by bacteria)
- Rheumatoid vasculitis (inflammation of veins with painful joints and morning stiffness)
male:
- Haemoglobin decreased
- Intestinal haemorrhage (bleeding from intestine)
- Furuncle (infection of the hair follicle)
- Oedema (fluid collection in tissue)
- Pneumonia
- Pyrexia (fever)
- Ascites (accumulation of fluid in the abdominal cavity)
- Cardiovascular disorder (heart diseases)
- Cardiovascular insufficiency (inadequate functioning of heart)
- Dehydration (dryness resulting from the removal of water)
What are the common drug interactions of Ebrantil and Voltaren, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Dizziness
- Hallucination, auditory (perceiving sounds without auditory stimulus)
- Respiratory distress (difficulty in breathing)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Myocarditis (inflammation of heart muscle myocardium)
- Septic shock (shock due to blood infection)
60+:
- Dehydration (dryness resulting from the removal of water)
- Urinary tract infection
- Rheumatoid vasculitis (inflammation of veins with painful joints and morning stiffness)
- Cellulitis (infection under the skin)
- Abdominal pain
- Restlessness (not able to rest)
- Urinary retention (the inability to completely or partially empty the bladder)
- Fatigue (feeling of tiredness)
- Gait disturbance
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 31.03%
- Osteoporosis (bones weak and more likely to break): 4 people, 13.79%
- Neurogenic Bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion): 4 people, 13.79%
- Pain In Extremity: 3 people, 10.34%
- Pain: 3 people, 10.34%
- Constipation: 3 people, 10.34%
- Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 6.90%
- Cancer Pain: 2 people, 6.90%
- Compression Fracture (fracture due to pressure caused by injury): 2 people, 6.90%
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 6.90%
* Approximation only. Some reports may have incomplete information.
Do you take Ebrantil and Voltaren?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ebrantil and Voltaren:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ebrantil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Voltaren:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ebrantil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Voltaren and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on urapidil and diclofenac sodium (the active ingredients of Ebrantil and Voltaren, respectively), and Ebrantil and Voltaren (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Migraine and Skin Plaque - a second ago
- Could Potassium Phosphate cause Neutropenia Aggravated? - 4 seconds ago
- Dry Eyes and Instillation Site Reaction - 4 seconds ago
- Drug Dependence and Consciousness - Decreased - 4 seconds ago
- Could Lupkynis cause Glomerular Filtration Rate Abnormal? - 5 seconds ago
- Could Gardasil cause Weakness? - 7 seconds ago
- Could Turalio cause Indigestion? - 9 seconds ago
- Could Doxycycline cause Blood Urine Present? - 11 seconds ago
- Depression and Shock - 14 seconds ago
- Could Enoxaparin Sodium cause Adrenocortical Insufficiency Acute? - 15 seconds ago